Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2014 2
2015 4
2016 4
2017 6
2018 4
2019 3
2020 4
2021 10
2022 10
2023 5
2024 15
2025 20
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial.
Leboulleux S, Bournaud C, Chougnet CN, Lamartina L, Zerdoud S, Do Cao C, Catargi B, Dygai I, Kelly A, Barge ML, Vera P, Rusu D, Schneegans O, Roux J, Raymond P, Benisvy D, Eberle MC, Bidault S, Nascimento C, Bastie D, Giraudet AL, Bardet S, Le Moullec N, Roudaut N, Drui D, Godbert Y, Zalzali M, Drutel A, Morel O, Velayoudom FL, Al Ghuzlan A, Schlumberger M, Buffet C, Borget I. Leboulleux S, et al. Among authors: buffet c. Lancet Diabetes Endocrinol. 2025 Jan;13(1):38-46. doi: 10.1016/S2213-8587(24)00276-6. Epub 2024 Nov 22. Lancet Diabetes Endocrinol. 2025. PMID: 39586309 Free article. Clinical Trial.
[Thyroiditis].
Buffet C, Groussin L. Buffet C, et al. Rev Prat. 2013 Feb;63(2):171-7. Rev Prat. 2013. PMID: 23513772 Review. French.
Which lymphadenectomy for adrenocortical carcinoma?
de Ponthaud C, Bekada S, Buffet C, Roy M, Bachelot A, Ayed A, Menegaux F, Gaujoux S. de Ponthaud C, et al. Among authors: buffet c. Surgery. 2024 Dec;176(6):1635-1644. doi: 10.1016/j.surg.2024.09.008. Epub 2024 Oct 5. Surgery. 2024. PMID: 39370320 Free article.
Redifferentiation of radioiodine-refractory thyroid cancers.
Buffet C, Wassermann J, Hecht F, Leenhardt L, Dupuy C, Groussin L, Lussey-Lepoutre C. Buffet C, et al. Endocr Relat Cancer. 2020 May;27(5):R113-R132. doi: 10.1530/ERC-19-0491. Endocr Relat Cancer. 2020. PMID: 32191916 Review.
An update on management of cytologically indeterminate thyroid nodules.
Roy M, Ghander C, Bigorgne C, Brière M, Deniziaut G, Ansart F, Lussey-Lepoutre C, Buffet C. Roy M, et al. Among authors: buffet c. Ann Endocrinol (Paris). 2025 Apr;86(2):101711. doi: 10.1016/j.ando.2025.101711. Epub 2025 Feb 15. Ann Endocrinol (Paris). 2025. PMID: 39961482 Free article. Review.
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer.
Lasolle H, Do Cao C, Lamartina L, Al Ghuzlan A, Drui D, Buffet C, Leboulleux S, Hescot S, Godbert Y, Zerdoud S, Ciappuccini R, Jannin A, Hadoux J, Borson-Chazot F. Lasolle H, et al. Among authors: buffet c. Ann Endocrinol (Paris). 2025 Jul;86(4):101733. doi: 10.1016/j.ando.2025.101733. Epub 2025 Apr 25. Ann Endocrinol (Paris). 2025. PMID: 40288439 Free article.
Chapter 11: Treatment modalities.
Baud G, Espiard S, Buffet C, Ben Hamou A, Henry H, Paladino NC, Sebag F, Goichot B. Baud G, et al. Among authors: buffet c. Ann Endocrinol (Paris). 2025 Feb;86(1):101700. doi: 10.1016/j.ando.2025.101700. Epub 2025 Jan 14. Ann Endocrinol (Paris). 2025. PMID: 39818297
French expert consensus statement on diagnosis and management of primary hyperparathyroidism.
Vantyghem MC, Mirallié E, Al-Salameh A, Aubert S, Barraud S, Baud G, Ben Hamou A, Bertocchio JP, Borson-Chazot F, Bouillet B, Briet C, Buffet C, Caiazzo R, Cardot-Bauters C, Cariou B, Chabre O, Chanson P, Charbit J, Chéreau N, Chevalier B, Cirenei C, Coppin L, Corvillain B, Christou N, Cuny T, Deandreis D, Deguelte S, Delemer B, Desailloud R, Do Cao C, Donatini G, Drui D, Dupeux M, Espiard S, Figueres L, Frey S, Ghanassia E, Ghander C, Gaujoux S, Goichot B, Groussin L, Gueorguieva I, Guérin C, Hadoux J, Haissaguerre M, Henry H, Hindié E, Houiller P, Jannin A, Kerlan V, Klein M, Koumakis E, Kuczma P, Ladsous M, Lasolle H, Le Bras M, Lecoq AL, Lemaitre M, Lifante JC, Linglart A, Lopez AG, Lussey-Lepoutre C, Luton D, Maione L, Marciniak C, Mathonnet M, Menegaux F, Molin A, Mosbah H, Nominé-Criqui C, Odou MF, Osman D, Paladino NC, Picart C, Romanet P, Santucci N, Scheyer N, Sebag F, Sokol E, Taieb D, Tauveron I, Tresallet C, Triponez F, Vergès B, Vezzosi D, Brunaud L, Kamenicky P. Vantyghem MC, et al. Among authors: buffet c. Ann Endocrinol (Paris). 2025 Sep;86(5):102449. doi: 10.1016/j.ando.2025.102449. Epub 2025 Aug 30. Ann Endocrinol (Paris). 2025. PMID: 40889554
84 results